Aristotle University Of Thessaloniki (AUTH)
Ο ρόλος της χορήγησης κορτιζόνης ενδοφλέβια ενδοτυμπανικά ή σε συνδυασμό στην αντιμετώπιση της ιδιοπαθούς οξείας πτώσης της ακοής
Abstract
dc:descriptionIdiopathic Sudden Sensorineural Hearing Loss (ISSHL) is an uncommon otologic condition with potentially serious consequences to the hearing of the affected individuals. The purpose of this prospective, randomized clinical trial was to compare the therapeutic efficacy of systemic versus intratympanic versus combined administration of steroids in the treatment of ISSHL. Additionally, the prognostic value of specific parameters from patients’ history, clinical presentation, laboratory and immunological profile was studied. 102 patients with an up to 14 days history of ISSHL were randomized to 1 of 3 arms and followed prospectively. Group A (35 patients) received prednisolone intravenously followed by methylprednisolone orally, whereas Group B (34 patients) were administered intratympanic methylprednisolone. Patients in Group C (33 patients) were administered the combination of the above mentioned treatment modalities. The patients were followed-up with pure tone audiograms on days 1 (initiation of treatment), 3, 5, 10, 30 and 90. The following audiometric criteria were used in order to assess hearing: Mean hearing gain (MHG) in 4 frequencies (0,5, 1, 2 and 4 KHz), in 5 frequencies (0,25, 0,5, 1, 2 and 4 KHz) and in 6 frequencies (0,25, 0,5, 1, 2, 4 and 8 KHz), Siegel’s criteria in 4 and 6 frequencies, hearing improvement criteria as defined by the Ministry of Health and Welfare in Japan and successful treatment defined as a hearing improvement of greater than 10 dB HL in pure tone average in 4 frequencies. The severity of tinnitus was evaluated using the questionnaire of Tinnitus Research Group of Japan Audiological Society, 1993. Finally, we investigated the effect of twenty four parameters to the prognosis of the disease. The final mean hearing gain was 29.0 dB HL for Group A, 27.0 dB HL for Group B and 29.9 dB HL for Group C when 4 frequencies were used. When 5 frequencies were used the respective mean hearing gains were 30.9, 26.4 and 30.5 dB HL whereas for 6 frequencies the respective mean hearing gains were 28.4, 24.7 and 28.0 dB HL. The final mean score for tinnitus was 6.42 for Group A, 5.87 for Group B and 6.36 for group C. No statistically significant differences were detected between the groups. Nevertheless, patients of Group B had the lowest rates of improved hearing whereas patients of Group C had the highest rates of significantly improved hearing. Older age, the presence of vertigo, history of smoking, profound hearing loss and abnormal hearing of the contralateral ear were strongly associated with poorer prognosis. The presence of tinnitus, history of heart disease and low levels of Thyroid Stimulating Hormone (TSH) were associated with a trend for poorer prognosis. Patients with a history of recent upper respiratory tract infection showed a trend for better hearing outcomes. The results of the present study suggest that treatment of ISSHL with systemic, intratympanic or combined administration of steroids result in similar rates of hearing improvement. Intratympanic steroids have the least therapeutic efficacy whereas combined treatment shows a trend for better hearing outcomes. Younger, non-smoking patients with less severe initial hearing loss and normal contralateral ear that do not present with vertigo, are more likely to achieve better hearing outcomes. History of recent upper respiratory tract infection, normal cardiac function, normal TSH levels and absence of tinnitus as part of the disease’s clinical presentation can potentially contribute to better prognosis.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2016
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Tsounis, Michail
- Τσούνης, Μιχαήλ
Subjects
dc:subject × 18- Αιφνίδια νευροαισθητήρια βαρηκοΐα
- Στεροειδή
- Ενδοτυμπανική έγχυση
- Συστηματική
- Συνδυασμός
- Ακοόγραμμα
- Προγνωστικοί παράγοντες
- Sudden sensorineural hearing loss
- Steroids
- Intratympanic injection
- Systemic
- Combination
- Audiogram
- Prognostic factors
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Medical and Health Sciences
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/39886